Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
From July 27, Novo Nordisk South Africa will launch an authorised, more affordable copy of their famous semaglutide molecule in partnership with Acino, part of Arcera, in a move the companies say is aimed at expanding access to treatment for people living with type 2 diabetes
Most people use it on the skin as a serum
The regulatory nod on 30 September 2025 allows the medication to address the rising prevalence of Type 2 diabetes and obesity in the country
Most weight loss peptides target one or some combination of these pathways
Laboratory studies show that dermal papilla cells treated with GHK-Cu exhibit 45% increased proliferation and 60% greater production of hair growth-promoting factors
Please note this post includes references to, and links to articles mentioning eating disorder behaviours
US$ 23.56
US$ 20.06
US$ 24.17
